This article was originally published here
J Am Assoc Nurse Pract. 2021 April 7th doi: 10.1097 / JXX.0000000000000595. Online before printing.
ABSTRACT
BACKGROUND: Diabetes mellitus...
RALEIGH, NC, April 15, 2021 / PRNewswire / - Precision Diabetes, Inc. (PDI), an emerging leader in precision diabetes diagnostics, announced results of a...
Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...